United States· US:59746-790_4b2dea9b-0302-70d2-e063-6394a90a9d1a

Carbamazepine

A carbamazepine product containing carbamazepine, registered in United States by Jubilant Cadista Pharmaceuticals Inc.. The same ATC class is registered in 18 of our 19 countries.

ATC N03AF01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCarbamazepineATCN03AF01REGISTER NO.US:59746-790_4b2dea9b…PACKS LISTED2CHECKEDSeptember 20, 2026

Where it is registered

Carbamazepine is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AF01 (carbamazepine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Carbamazepine · ATC N03AF01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of carbamazepine costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $0.39 in France to $1.99 in United States — a ×5.2 gap.

  • United States: $1.99 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Carbamazepine · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • US United States$1.99 (acquisition cost)
  • CH Switzerland$1.35
  • IT Italy$0.46
  • FR France$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CARBAMAZEPINE
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.
Country
United States (US)
ATC code
N03AF01
ATC class
Carbamazepine
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 20, 2026

Packs & prices · 2

  • ndc11
    5974679001
    100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59746-790-01)
  • ndc11
    59746-790-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

614 interactions on record for carbamazepine.

Graded by severity as the source publishes them — 136 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Carbamazepine · interactions on record

614 records

  • 136 severe
  • 250 moderate
  • 6 minor
  • 133 info

Most severe, free to view

  • RolapitantA04AD14severe
  • NaloxegolA06AH03severe
  • NaldemedineA06AH05severe
  • EliglustatA16AX10severe

89 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Carbamazepine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carbamazepine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Neurotop, Neurotop Retard
  • Belgium · Tegretol, Tegretol Cr
  • Bulgaria · Neurotop, Neurotop Retard
  • Cyprus · Storilat, Storilat R
  • Czechia · Biston, Neurotop
  • Germany · Carba Retard, Carbadura
  • Denmark · Tegretol, Tegretol Retard
  • Estonia · Carbalex, Carbalex Retard
  • Spain · Carbamazepina Normon, Carbamazepina Vegal
  • Finland · Carbamazepine Essential Pharma, Neurotol Slow
  • France · Carbamazepine L.P. Sandoz, Carbamazepine Viatris
  • United Kingdom (Northern Ireland) · Carbagen, Carbamazepine
  • Greece · Tegretol
  • Croatia · Karbamazepin Tillomed, Tegretol
  • Hungary · Carbamazepine Essential Pharma, Neurotop
  • Ireland · Carbamazepine Azure Pharmaceuticals, Carbamazepine Essential Pharma
  • Iceland · Tegretol, Tegretol Retard
  • Italy · Carbamazepina Aurobindo, Carbamazepina Eg
  • Lithuania · Carbalex, Carbatol
  • Luxembourg · Tegretol, Tegretol Cr
  • Latvia · Carbalex, Carbalex Retard
  • Malta · Tegretol, Tegretol Cr
  • Netherlands · Carbamazepine Aurobindo, Carbamazepine Cf
  • Norway · Carbamazepine Essential Pharma, Tegretol
  • Poland · Amizepin, Finlepsin
  • Portugal · Carbamazepina Generis, Carbamazepina Generis Phar
  • Romania · Carbamazepin Bioeel, Carbamazepină Arena
  • Sweden · Carbamazepine Essential Pharma, Carbamazepine Tillomed
  • Slovenia · Tegretol, Tegretol Cr
  • Slovakia · Biston, Neurotop Retard

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f40f39b8-e2c5-4340-91e5-b2a8d61c28c3
GET /v1/drugs/f40f39b8-e2c5-4340-91e5-b2a8d61c28c3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "CARBAMAZEPINE",
  "productndc": "59746-790",
  "dosage_form": "TABLET, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA216594",
  "marketing_category": "ANDA"
}

See everything about carbamazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.